Abstract
In 2008, the UK introduced a human papillomavirus (HPV) immunisation programme for girls as a bivalent vaccine protecting for HPV-16/18. HPV-16 and HPV-18 are responsible for more than 70% of cervical cancers. In 2012 the programme switched to quadrivalent vaccine (HPV-6/11/16/18), which also protects against genital warts.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
